GB1302572A - - Google Patents
Info
- Publication number
- GB1302572A GB1302572A GB1644570A GB1644570A GB1302572A GB 1302572 A GB1302572 A GB 1302572A GB 1644570 A GB1644570 A GB 1644570A GB 1644570 A GB1644570 A GB 1644570A GB 1302572 A GB1302572 A GB 1302572A
- Authority
- GB
- United Kingdom
- Prior art keywords
- monocyclic
- cycloalkyl
- ols
- steroids
- novel
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- -1 C2U Steroids Chemical class 0.000 abstract 2
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 125000002950 monocyclic group Chemical group 0.000 abstract 2
- NDVLTYZPCACLMA-UHFFFAOYSA-N silver oxide Chemical compound [O-2].[Ag+].[Ag+] NDVLTYZPCACLMA-UHFFFAOYSA-N 0.000 abstract 2
- 150000003431 steroids Chemical class 0.000 abstract 2
- 229910052783 alkali metal Inorganic materials 0.000 abstract 1
- 150000001340 alkali metals Chemical class 0.000 abstract 1
- 230000003110 anti-inflammatory effect Effects 0.000 abstract 1
- 229910052799 carbon Inorganic materials 0.000 abstract 1
- 239000011203 carbon fibre reinforced carbon Substances 0.000 abstract 1
- 239000000969 carrier Substances 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 150000002170 ethers Chemical class 0.000 abstract 1
- 239000003862 glucocorticoid Substances 0.000 abstract 1
- 150000004820 halides Chemical class 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
- BWHLPLXXIDYSNW-UHFFFAOYSA-N ketorolac tromethamine Chemical compound OCC(N)(CO)CO.OC(=O)C1CCN2C1=CC=C2C(=O)C1=CC=CC=C1 BWHLPLXXIDYSNW-UHFFFAOYSA-N 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 239000001301 oxygen Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 229910001923 silver oxide Inorganic materials 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US82204969A | 1969-05-05 | 1969-05-05 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1302572A true GB1302572A (en:Method) | 1973-01-10 |
Family
ID=25234977
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB1644570A Expired GB1302572A (en:Method) | 1969-05-05 | 1970-04-07 |
Country Status (4)
| Country | Link |
|---|---|
| DE (1) | DE2021718A1 (en:Method) |
| FR (1) | FR2044764B1 (en:Method) |
| GB (1) | GB1302572A (en:Method) |
| NL (1) | NL7005500A (en:Method) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5420120A (en) * | 1993-12-17 | 1995-05-30 | Alcon Laboratories, Inc. | Anti-inflammatory glucocorticoid compounds for topical ophthalmic use |
| US5446177A (en) * | 1984-12-28 | 1995-08-29 | Alcon Laboratories, Inc. | Anti-inflammatory compounds for ophthalmic use |
| US8637662B2 (en) | 2009-09-11 | 2014-01-28 | Chiesi Farmaceutici S.P.A. | Isoxazolidine derivatives |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2966486A (en) * | 1959-03-20 | 1960-12-27 | American Cyanamid Co | 16alpha, 17alpha-substituted methylene dioxy ethers of steroids of the pregnane series and method of preparing the same |
-
1970
- 1970-04-07 GB GB1644570A patent/GB1302572A/en not_active Expired
- 1970-04-16 NL NL7005500A patent/NL7005500A/xx unknown
- 1970-04-28 FR FR7015562A patent/FR2044764B1/fr not_active Expired
- 1970-05-04 DE DE19702021718 patent/DE2021718A1/de active Pending
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5446177A (en) * | 1984-12-28 | 1995-08-29 | Alcon Laboratories, Inc. | Anti-inflammatory compounds for ophthalmic use |
| US5420120A (en) * | 1993-12-17 | 1995-05-30 | Alcon Laboratories, Inc. | Anti-inflammatory glucocorticoid compounds for topical ophthalmic use |
| US8637662B2 (en) | 2009-09-11 | 2014-01-28 | Chiesi Farmaceutici S.P.A. | Isoxazolidine derivatives |
Also Published As
| Publication number | Publication date |
|---|---|
| FR2044764A1 (en:Method) | 1971-02-26 |
| FR2044764B1 (en:Method) | 1974-04-12 |
| DE2021718A1 (de) | 1970-11-19 |
| NL7005500A (en:Method) | 1970-11-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB1429922A (en) | Steroid acetals processes for their manufacture and preparations containing them | |
| GB1163737A (en) | Improvements in or relating to 7-Dihalomethyl Steroids | |
| GB1302572A (en:Method) | ||
| GB1363472A (en) | 17-chlorosteroids | |
| GB1440064A (en) | Delta8-9- steroids of the pregnane series | |
| GB1242981A (en) | 07alpha,21-ORTHOCARBONATES OF STEROID-DERIVATIVES AND PROCESS FOR PREPARING THEM | |
| GB1269291A (en) | Improvements in or relating to corticoid carbonates | |
| GB1434378A (en) | Cyano-pregnene compounds | |
| GB1164067A (en) | Acetals and Ketals of 3beta-(&alpha-L-rhamnosido)-04beta-hydroxy-19-oxo(or-hydroxy)-bufa-4,20,22-trienolides | |
| IE34930B1 (en) | 21-esters of fluocinolone-acetonide | |
| GB1527249A (en) | 6-fluoro-16-methyl-pregna-1,4,8-triene-3,20-diones | |
| GB1272688A (en) | Sulphamido-steroids and the preparation thereof | |
| GB1444154A (en) | 15alpha, 16alpha-delta4-pregnenes | |
| GB1208230A (en) | Novel esters of 21-hydroxy-pregnanes, processes for their preparation, and compositions incorporating them | |
| GB1303008A (en:Method) | ||
| IE42468L (en) | 13-ethynyl- and 13-(2 halovinyl)-steroids | |
| GB1317185A (en) | Acyloxy-3alpha-hydroxy-pregnones | |
| GB1128789A (en) | 7ª-alkyl-5(10),9(11)-diene steroids | |
| GB1202724A (en) | 3-ALKYLENEDIOXY-4-CHLORO-6-ALKYL-17alpha-ACYLOXY-Delta<4>-PREGNEN-20-ONES AND PROCESS FOR THEIR MANUFACTURE | |
| CA632910A (en) | Spaced reinforcement of shaped structures from fiber-forming materials | |
| GB1236474A (en) | 3-oxo-a,19-bis-nor-b-homo-steroid-5(10)-enes and process for their manufacture | |
| GB1160212A (en) | Process for the Manufacture of Steroid Keto-Aldehydes | |
| GB1149504A (en) | Improvements in or relating to 19-methyl-19-oxo derivatives of androstane and pregnane | |
| GB1196476A (en) | 21-Fluoro-Delta<4,6>-Pregnadienes and process for their manufacture | |
| GB1289020A (en:Method) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PS | Patent sealed | ||
| PLNP | Patent lapsed through nonpayment of renewal fees |